However, when individual patient plasmas were analyzed by ELISA, statistically significant ADAMDEC1 expression level differences (p ≤ 0.05) were only found between stage II CRC plasmas and healthy controls (n = 20) (Fig. 5c). The gene discussed is ADAMDEC1; the disease is colorectal carcinoma.